Literature DB >> 12161016

The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats.

Leda Gaspani1, Mauro Bianchi, Elena Limiroli, Alberto E Panerai, Paola Sacerdote.   

Abstract

Surgery stress has been shown to be associated in rat with decreased natural killer (NK) cell activity and enhancement of tumor metastasis. We have previously shown that the analgesic drug tramadol stimulates NK activity both in the rodent and in the human. In the present study, we analyze, in the rat, tramadol ability to prevent the effect of experimental surgery on NK activity and on the enhancement of metastatic diffusion to the lung of the NK sensitive tumor model MADB106. The administration of tramadol (20 and 40 mg/kg) before and after laparatomy significantly blocked the enhancement of lung metastasis induced by surgery. In contrast, the administration of 10 mg/kg of morphine was not able to modify this enhancement. The modulation of NK activity seemed to play a central role in the effect of tramadol on MADB106 cells. In fact, both doses of tramadol were able to prevent surgery-induced NK activity suppression, while the drug significantly increased NK activity in normal non-operated animals. Morphine, that in normal rats significantly decreased NK cytotoxicity, did not prevent surgery-induced immunosuppression. The good analgesic efficacy of tramadol combined with its intrinsic immunostimulatory properties suggests that this analgesic drug can be particularly indicated in the control of peri-operative pain in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161016     DOI: 10.1016/s0165-5728(02)00165-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  34 in total

1.  Enhancing antitumor immunity perioperatively: a matter of timing, cooperation, and specificity.

Authors:  Jeffrey L Curtis; Antonello Punturieri
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05       Impact factor: 6.914

2.  Laparoscopic surgery for palliative resection of the primary tumor in incurable stage IV colorectal cancer.

Authors:  Hideaki Nishigori; Masaaki Ito; Yuji Nishizawa; Atsushi Kohyama; Takamaru Koda; Kentaro Nakajima; Yusuke Nishizawa; Akihiro Kobayashi; Masanori Sugito; Norio Saito
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

3.  Laparoscopic palliative surgery for complicated colorectal cancer.

Authors:  R Gonzalez; C D Smith; E M Ritter; E Mason; T Duncan; B J Ramshaw
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

4.  Suppression of Human Natural Killer Cells by Different Classes of Opioids.

Authors:  Dermot P Maher; Deepa Walia; Nicola M Heller
Journal:  Anesth Analg       Date:  2019-05       Impact factor: 5.108

Review 5.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

Review 6.  Clinical pharmacology of tramadol.

Authors:  Stefan Grond; Armin Sablotzki
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  [Interaction of anesthetics and analgesics with tumor cells].

Authors:  A Bundscherer; M Malsy; D Bitzinger; B M Graf
Journal:  Anaesthesist       Date:  2014-04       Impact factor: 1.041

8.  Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain.

Authors:  Yong-Min Liu; Sheng-Mei Zhu; Kui-Rong Wang; Zhi-Ying Feng; Qing-Lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

Review 9.  Chronic opioid therapy in long-term cancer survivors.

Authors:  A Carmona-Bayonas; P Jiménez-Fonseca; E Castañón; A Ramchandani-Vaswani; R Sánchez-Bayona; A Custodio; D Calvo-Temprano; J A Virizuela
Journal:  Clin Transl Oncol       Date:  2016-07-21       Impact factor: 3.405

10.  Surgical stress promotes tumor growth in ovarian carcinoma.

Authors:  Jeong-Won Lee; Mian M K Shahzad; Yvonne G Lin; Guillermo Armaiz-Pena; Lingegowda S Mangala; Hee-Dong Han; Hye-Sun Kim; Eun Ji Nam; Nicholas B Jennings; Jyotsnabaran Halder; Alpa M Nick; Rebecca L Stone; Chunhua Lu; Susan K Lutgendorf; Steve W Cole; Anna E Lokshin; Anil K Sood
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.